BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 24588871)

  • 1. Experimental evidence of good efficacy and reduced toxicity with peptide-doxorubicin to treat gastric cancer.
    Zhang J; Yuan JP; Wang Q; Shao LH; Liu SP; Firestone RA; Hong YP; Li JG; Xin YC; Li Y
    Oncotarget; 2018 Jan; 9(2):1957-1968. PubMed ID: 29416744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and identification of a rabbit model of peritoneal carcinomatosis from gastric cancer.
    Mei LJ; Yang XJ; Tang L; Hassan AH; Yonemura Y; Li Y
    BMC Cancer; 2010 Apr; 10():124. PubMed ID: 20359350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cathepsin B-Overexpressed Tumor Cell Activatable Albumin-Binding Doxorubicin Prodrug for Cancer-Targeted Therapy.
    Cho H; Shim MK; Yang S; Song S; Moon Y; Kim J; Byun Y; Ahn CH; Kim K
    Pharmaceutics; 2021 Dec; 14(1):. PubMed ID: 35056979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: results of the GYMSSA trial.
    Rudloff U; Langan RC; Mullinax JE; Beane JD; Steinberg SM; Beresnev T; Webb CC; Walker M; Toomey MA; Schrump D; Pandalai P; Stojadinovic A; Avital I
    J Surg Oncol; 2014 Sep; 110(3):275-84. PubMed ID: 25042700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical In Vivo-Models to Investigate HIPEC; Current Methodologies and Challenges.
    Helderman RFCPA; Löke DR; Tanis PJ; Tuynman JB; Ceelen W; de Hingh IH; van der Speeten K; Franken NAP; Oei AL; Kok HP; Crezee J
    Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of Sodium Selenite and Doxorubicin Prodrug Ac-Phe-Lys-PABC-ADM Affects Gastric Cancer Cell Apoptosis in Xenografted Mice.
    Wu B; Ge J; Zhang Z; Huang C; Li X; Tan Z; Fang X; Sun J
    Biomed Res Int; 2019; 2019():2486783. PubMed ID: 31531348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Animal models of colorectal peritoneal metastasis.
    Gremonprez F; Willaert W; Ceelen W
    Pleura Peritoneum; 2016 Mar; 1(1):23-43. PubMed ID: 30911606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, Characterization and in vitro Studies of a Cathepsin B-Cleavable Prodrug of the VEGFR Inhibitor Sunitinib.
    Karnthaler-Benbakka C; Koblmüller B; Mathuber M; Holste K; Berger W; Heffeter P; Kowol CR; Keppler BK
    Chem Biodivers; 2019 Jan; 16(1):e1800520. PubMed ID: 30566287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel delivery approaches for cancer therapeutics.
    Mitra AK; Agrahari V; Mandal A; Cholkar K; Natarajan C; Shah S; Joseph M; Trinh HM; Vaishya R; Yang X; Hao Y; Khurana V; Pal D
    J Control Release; 2015 Dec; 219():248-268. PubMed ID: 26456750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment and prevention of peritoneal carcinomatosis from gastric cancer by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: overview and rationale.
    Roviello F; Caruso S; Neri A; Marrelli D
    Eur J Surg Oncol; 2013 Dec; 39(12):1309-16. PubMed ID: 24183797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 30-year experience-A meta-analysis of randomised and high-quality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer.
    Desiderio J; Chao J; Melstrom L; Warner S; Tozzi F; Fong Y; Parisi A; Woo Y
    Eur J Cancer; 2017 Jul; 79():1-14. PubMed ID: 28456089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, identification and in vivo studies of tumor-targeting agent peptide doxorubicin (PDOX) to treat peritoneal carcinomatosis of gastric cancer with similar efficacy but reduced toxicity.
    Tang L; Duan R; Zhong YJ; Firestone RA; Hong YP; Li JG; Xin YC; Wu HL; Li Y
    Mol Cancer; 2014 Mar; 13():44. PubMed ID: 24588871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cathepsin B cleavable novel prodrug Ac-Phe-Lys-PABC-ADM enhances efficacy at reduced toxicity in treating gastric cancer peritoneal carcinomatosis: an experimental study.
    Shao LH; Liu SP; Hou JX; Zhang YH; Peng CW; Zhong YJ; Liu X; Liu XL; Hong YP; Firestone RA; Li Y
    Cancer; 2012 Jun; 118(11):2986-96. PubMed ID: 22006342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting therapy of hepatocellular carcinoma with doxorubicin prodrug PDOX increases anti-metastatic effect and reduces toxicity: a preclinical study.
    Wang Q; Zhong YJ; Yuan JP; Shao LH; Zhang J; Tang L; Liu SP; Hong YP; Firestone RA; Li Y
    J Transl Med; 2013 Aug; 11():192. PubMed ID: 23961994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival of gastric cancer with peritoneal carcinomatosis: evidence from an experimental study.
    Tang L; Mei LJ; Yang XJ; Huang CQ; Zhou YF; Yonemura Y; Li Y
    J Transl Med; 2011 May; 9():53. PubMed ID: 21548973
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.